146 Free fetal haemoglobin impacts fetoplacental vascular structure and function: implications for fetal growth restriction
IntroductionIn fetal growth restriction (FGR), early placentation defects result in placental insufficiency and vasoconstriction, which cumulate in organ failure at the severe end of the spectrum. In other placental pathologies, including preeclampsia, extracellular free fetal haemoglobin (fHbF) is...
Saved in:
Published in | Heart (British Cardiac Society) Vol. 103; no. Suppl 5; p. A108 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
01.06.2017
|
Online Access | Get full text |
Cover
Loading…
Abstract | IntroductionIn fetal growth restriction (FGR), early placentation defects result in placental insufficiency and vasoconstriction, which cumulate in organ failure at the severe end of the spectrum. In other placental pathologies, including preeclampsia, extracellular free fetal haemoglobin (fHbF) is overproduced, where it inactivates the vasodilator nitric oxide (NO). We have previously shown that excess fetoplacental fHbF also occurs in FGR pregnancy, sequestering NO and evoking vasoconstriction. Here, we explore the further effects of fHbF on fetoplacental endothelium, considering altered angiogenesis, altered vasculoprotection, and an immunological response.MethodsWe assessed the fHbF evoked synthesis of the pro-angiogenic and pro-inflammatory cell stress mediators DKK-4, NFkB and FABP-1, produced by human chorionic plate arterial endothelial cells (HPAECs) under conditions of unidirectional laminar flow. Secondly, we studied fHbF-evoked NFà °B nuclear translocation using fluorescent microscopy; and the downstream NFkB-actuated cytokine profile (IF1α, TNFα) measured in cell medium and lysate by ELISA. Observations were expanded to assessment of fHbF effects on branching and non-branching angiogenesis of HPAECs grown on Matrigel, and expressed as an average of tubule length multiplied by tubule number as a net measure of angiogenesis. As a correlate, endothelial morphology of fHbF and non-exposed static chorionic artery sections was qualitatively analysed by scanning electron microscopy.ResultsA cell stress proteome assay demonstrated that fHbF increased synthesis of DKK-4 (>50% increase from control), NFκB (>50% increase) and FABP1 (>100% increase). A pro-angiogenic effect was further corroborated by assessment of villous angiogenesis on Matrigel, where 0.3 mg/ml fHbF was found to promote branching angiogenesis in HPAECs (n=5; p<0.01). In a separate study of NFκB-mediated endothelial inflammation, 0.3 mg/ml fHbF-evoked NFkB signal transduction demonstrable by nuclear translocation within 2.5 hours, whilst in controls no evidence of NFkB activation was observed (n=4 paired lines). In the fHbF group this was paralleled by increased release of NFκB-actuated cytokines into flow-conditioned medium, IFN1± (n=7; control vs. fHbF-exposed at 0.2 mg/ml fHbF median fold change 1.42 (range 1.09–2.2) vs. 1 (0); Wilcoxon p<0.05), and for TNFα ?(control vs. fHbF-exposed at 0.2 mg/ml fHbF median fold-change 1.54 (range 1.09–2.22) vs. 1 (0); Wilcoxon p<0.05). Morphologically, fHbF evoked widespread blebbing of the luminal endothelium.ConclusionfHbF causes aberrant pro-angiogenesis, promotes acute inflammation and loss of structural organisation in fetoplacental endothelium. Our findings are relevant to widening understanding the pathophysiology of FGR and exploring the link between FGR and stillbirth, where overproduction of extracellular fetal haemoglobin could represent a novel therapeutic target. |
---|---|
AbstractList | Introduction In fetal growth restriction (FGR), early placentation defects result in placental insufficiency and vasoconstriction, which cumulate in organ failure at the severe end of the spectrum. In other placental pathologies, including preeclampsia, extracellular free fetal haemoglobin (fHbF) is overproduced, where it inactivates the vasodilator nitric oxide (NO). We have previously shown that excess fetoplacental fHbF also occurs in FGR pregnancy, sequestering NO and evoking vasoconstriction. Here, we explore the further effects of fHbF on fetoplacental endothelium, considering altered angiogenesis, altered vasculoprotection, and an immunological response. Methods We assessed the fHbF evoked synthesis of the pro-angiogenic and pro-inflammatory cell stress mediators DKK-4, NFkB and FABP-1, produced by human chorionic plate arterial endothelial cells (HPAECs) under conditions of unidirectional laminar flow. Secondly, we studied fHbF-evoked NFà °B nuclear translocation using fluorescent microscopy; and the downstream NFkB-actuated cytokine profile (IF1α, TNFα) measured in cell medium and lysate by ELISA. Observations were expanded to assessment of fHbF effects on branching and non-branching angiogenesis of HPAECs grown on Matrigel, and expressed as an average of tubule length multiplied by tubule number as a net measure of angiogenesis. As a correlate, endothelial morphology of fHbF and non-exposed static chorionic artery sections was qualitatively analysed by scanning electron microscopy. Results A cell stress proteome assay demonstrated that fHbF increased synthesis of DKK-4 (>50% increase from control), NFκB (>50% increase) and FABP1 (>100% increase). A pro-angiogenic effect was further corroborated by assessment of villous angiogenesis on Matrigel, where 0.3 mg/ml fHbF was found to promote branching angiogenesis in HPAECs (n=5; p<0.01). In a separate study of NFκB-mediated endothelial inflammation, 0.3 mg/ml fHbF-evoked NFkB signal transduction demonstrable by nuclear translocation within 2.5 hours, whilst in controls no evidence of NFkB activation was observed (n=4 paired lines). In the fHbF group this was paralleled by increased release of NFκB-actuated cytokines into flow-conditioned medium, IFN1± (n=7; control vs. fHbF-exposed at 0.2 mg/ml fHbF median fold change 1.42 (range 1.09-2.2) vs. 1 (0); Wilcoxon p<0.05), and for TNFα ?(control vs. fHbF-exposed at 0.2 mg/ml fHbF median fold-change 1.54 (range 1.09-2.22) vs. 1 (0); Wilcoxon p<0.05). Morphologically, fHbF evoked widespread blebbing of the luminal endothelium. Conclusion fHbF causes aberrant pro-angiogenesis, promotes acute inflammation and loss of structural organisation in fetoplacental endothelium. Our findings are relevant to widening understanding the pathophysiology of FGR and exploring the link between FGR and stillbirth, where overproduction of extracellular fetal haemoglobin could represent a novel therapeutic target. IntroductionIn fetal growth restriction (FGR), early placentation defects result in placental insufficiency and vasoconstriction, which cumulate in organ failure at the severe end of the spectrum. In other placental pathologies, including preeclampsia, extracellular free fetal haemoglobin (fHbF) is overproduced, where it inactivates the vasodilator nitric oxide (NO). We have previously shown that excess fetoplacental fHbF also occurs in FGR pregnancy, sequestering NO and evoking vasoconstriction. Here, we explore the further effects of fHbF on fetoplacental endothelium, considering altered angiogenesis, altered vasculoprotection, and an immunological response.MethodsWe assessed the fHbF evoked synthesis of the pro-angiogenic and pro-inflammatory cell stress mediators DKK-4, NFkB and FABP-1, produced by human chorionic plate arterial endothelial cells (HPAECs) under conditions of unidirectional laminar flow. Secondly, we studied fHbF-evoked NFà °B nuclear translocation using fluorescent microscopy; and the downstream NFkB-actuated cytokine profile (IF1α, TNFα) measured in cell medium and lysate by ELISA. Observations were expanded to assessment of fHbF effects on branching and non-branching angiogenesis of HPAECs grown on Matrigel, and expressed as an average of tubule length multiplied by tubule number as a net measure of angiogenesis. As a correlate, endothelial morphology of fHbF and non-exposed static chorionic artery sections was qualitatively analysed by scanning electron microscopy.ResultsA cell stress proteome assay demonstrated that fHbF increased synthesis of DKK-4 (>50% increase from control), NFκB (>50% increase) and FABP1 (>100% increase). A pro-angiogenic effect was further corroborated by assessment of villous angiogenesis on Matrigel, where 0.3 mg/ml fHbF was found to promote branching angiogenesis in HPAECs (n=5; p<0.01). In a separate study of NFκB-mediated endothelial inflammation, 0.3 mg/ml fHbF-evoked NFkB signal transduction demonstrable by nuclear translocation within 2.5 hours, whilst in controls no evidence of NFkB activation was observed (n=4 paired lines). In the fHbF group this was paralleled by increased release of NFκB-actuated cytokines into flow-conditioned medium, IFN1± (n=7; control vs. fHbF-exposed at 0.2 mg/ml fHbF median fold change 1.42 (range 1.09–2.2) vs. 1 (0); Wilcoxon p<0.05), and for TNFα ?(control vs. fHbF-exposed at 0.2 mg/ml fHbF median fold-change 1.54 (range 1.09–2.22) vs. 1 (0); Wilcoxon p<0.05). Morphologically, fHbF evoked widespread blebbing of the luminal endothelium.ConclusionfHbF causes aberrant pro-angiogenesis, promotes acute inflammation and loss of structural organisation in fetoplacental endothelium. Our findings are relevant to widening understanding the pathophysiology of FGR and exploring the link between FGR and stillbirth, where overproduction of extracellular fetal haemoglobin could represent a novel therapeutic target. |
Author | Crocker, Ian Sneyd, Rosie Gurung, Rekha Hansson, Stefan Brownbill, Paul Brook, Adam |
Author_xml | – sequence: 1 givenname: Adam surname: Brook fullname: Brook, Adam organization: Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Lund University – sequence: 2 givenname: Rosie surname: Sneyd fullname: Sneyd, Rosie organization: Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Lund University – sequence: 3 givenname: Rekha surname: Gurung fullname: Gurung, Rekha organization: Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Lund University – sequence: 4 givenname: Stefan surname: Hansson fullname: Hansson, Stefan organization: Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Lund University – sequence: 5 givenname: Ian surname: Crocker fullname: Crocker, Ian organization: Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Lund University – sequence: 6 givenname: Paul surname: Brownbill fullname: Brownbill, Paul organization: Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Lund University |
BookMark | eNqNkMFKxDAQhoOs4Lr6DgHPXTNNmmy9yeKqsOBFwVtI03S3pU1q2ioeBC--qE9iate75JDM5Ptm4D9FM-usQQgDWQJQfrk3yveVraOYgIgogIj5ElhyhObA-GpsP8_CmyZJxAkVJ-i06ypCCEtXfI4-AvT9-bXxxuDC9KrGe2Uat6tdVlpcNq3SfTf-uLZW2tiReFWdHmrlcdf7QfeDN1jZHBeD1X3p7NWo1aVWYxFc5w-Td9699XvsTfDKX_QMHReq7sz54V6gp83N4_ou2j7c3q-vt1EGApKI5olKM2IYo7RIIKEspkTxVAsCTIucQ2aMCA2e5SmjWSqEpuHomBXUaEEX6GKa23r3MoT9snKDt2GlhJRwGgQggVpNlPau67wpZOvLRvl3CUSOYcu_sOUYtpzCliHsoNJJzZrq_9YPf2WKcw |
ContentType | Journal Article |
Copyright | 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions Copyright: 2017 (c) 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
Copyright_xml | – notice: 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions – notice: Copyright: 2017 (c) 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 88I 8AF 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. M0S M1P M2P PQEST PQQKQ PQUKI Q9U |
DOI | 10.1136/heartjnl-2017-311726.145 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic |
DatabaseTitle | CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest Central Student |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-201X |
EndPage | A108 |
ExternalDocumentID | 4322731687 10_1136_heartjnl_2017_311726_145 |
GroupedDBID | --- .55 .VT 0R~ 29I 2WC 354 39C 3O- 3V. 4.4 40O 53G 5GY 5RE 7X7 7~S 88E 88I 8AF 8FI 8FJ 8R4 8R5 AAFWJ AAHLL AAKAS AAOJX AAWJN AAWTL AAYEP ABAAH ABJNI ABKDF ABMQD ABOCM ABUWG ABVAJ ACGFS ACGOD ACGTL ACHTP ACMFJ ACOFX ACTZY ADBBV ADCEG ADUGQ ADZCM AEKJL AENEX AFFNX AFKRA AFWFF AHMBA AHNKE AHQMW AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZFZN AZQEC BAWUL BCR BENPR BLC BLJBA BOMFT BPHCQ BTHHO BVXVI C1A CAG CCPQU COF CXRWF DIK DU5 DWQXO E3Z EBS EJD EX3 F5P FEDTE FYUFA GNUQQ GX1 H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IHR INH INR IOF ITC J5H L7B M1P M2P N4W N9A NTWIH NXWIF O9- OK1 OVD P2P PCD PEA PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VM9 WH7 WOQ WOW X7M YFH YQY ZGI ZXP AAYXX CITATION 7XB 8FK K9. PQEST PQUKI Q9U |
ID | FETCH-LOGICAL-b1715-3d5a9b0e4433f51534230a69c7014c7d61bee7a696bd943b977c3c3cc24f3ec73 |
IEDL.DBID | BENPR |
ISSN | 1355-6037 |
IngestDate | Wed Aug 28 13:50:59 EDT 2024 Fri Aug 23 02:32:06 EDT 2024 Wed Aug 21 02:05:38 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b1715-3d5a9b0e4433f51534230a69c7014c7d61bee7a696bd943b977c3c3cc24f3ec73 |
OpenAccessLink | https://heart.bmj.com/content/heartjnl/103/Suppl_5/A108.2.full.pdf |
PQID | 1906397710 |
PQPubID | 2041068 |
ParticipantIDs | proquest_journals_1906397710 crossref_primary_10_1136_heartjnl_2017_311726_145 bmj_primary_10_1136_heartjnl_2017_311726_145 |
PublicationCentury | 2000 |
PublicationDate | 20170600 2017-06-00 20170601 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: 20170600 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Heart (British Cardiac Society) |
PublicationYear | 2017 |
Publisher | BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group LTD |
SSID | ssj0004986 |
Score | 2.2536106 |
Snippet | IntroductionIn fetal growth restriction (FGR), early placentation defects result in placental insufficiency and vasoconstriction, which cumulate in organ... Introduction In fetal growth restriction (FGR), early placentation defects result in placental insufficiency and vasoconstriction, which cumulate in organ... |
SourceID | proquest crossref bmj |
SourceType | Aggregation Database Publisher |
StartPage | A108 |
Title | 146 Free fetal haemoglobin impacts fetoplacental vascular structure and function: implications for fetal growth restriction |
URI | http://dx.doi.org/10.1136/heartjnl-2017-311726.145 https://www.proquest.com/docview/1906397710/abstract/ |
Volume | 103 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFA-bA_EifuI3OXg0bFnSxHoRFccQHCIKu5WkfdWJ6-Y2T_7zvpe2yi6C9NYkPbyXvt_7foydeplHWvtYUO8zgQilhVNWitxmcddDBy2CkG0xMP1nfTeMhg3Wr2thKK2ylolBUGeTlHzkbQQuikEhILadJy9AumhfTj8EzY-iOGs1TKPJWl2pKWDbur4dPDz-1kjGYeqjRHwVpqNsndWjTJtGRy_eine8MZKcdojpBiUIwY0fvy0D1rK8DiDU22DrlfbIr0p2b7IGFFts9b6Kj2-zL5RIvDcD4DmgVs1fHYwn1PNjVPCyHnJOK5OQiUV1kLzOROVlI9nPGXBXZJzgjlh2Qcd-_HocNdzqyy9ovi9eOU32mI3C1h323Lt9uumLaryC8NLKSKgscrHvgNZK5ajWUC_AjjNxatFsSm1mpAew-ML4LNbKI_FThU_a1bmC1KpdtlJMCthj3CHJUJHLjXOR9h7O1TlkkGvwkbfaRPvsDCmZTMsGGkkwPJRJasInRPikJDzaIrhd1iT_x5mjmjdJ9RvOk99Lc_D38iFbC8wP7pUjtoIkh2PUNhb-hDXt0J5U1-kbJkPUFw |
link.rule.ids | 315,786,790,12083,21416,27957,27958,31754,33779,43345,43840,74102,74659 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDI5gSMAF8RSPATlwJNq6pMnKBSHENGDbaZN2q5rWhU2sG9s48eex05ZpFyTUW5P08MX1ZzuOzdiN9VJfKRsIqn0mkKGUiKTxRGqSoGGhjh6By7bo6fZAvQz9YRFwWxRplaVOdIo6mcYUI68hcdEZFBLi_exTUNcoOl0tWmhssi0lpaKUPjM0q3uRgev06CGnCl2XpszkkbpG7aKX4-wDpcSjQB3yuEatQRRjJ-N1klrX0Y54Wvtsr7AY-UO-xQdsA7JDtt0tzsSP2DdqId6aA_AU0JLm7xFMplTnY5Tx_A7kgkamLvuK7j7yMvuU58Vjv-bAoyzhRHG0TXe07DeWx9GqLb78hi778p1TN4_5yE09ZoPWU_-xLYqWCsJ6xvOFTPwosHVQCFeKpgzV_6tHOogNukqxSbRnAQy-0DYJlLQIeCzxiRsqlRAbecIq2TSDU8YjhAyNt1RHka-shaZsQgKpAutbo7R_xm4RyXCWF80InbMhdVgCHxLwYQ48-h843Ssh_8eaark3YfHrLcKVoJz_PXzNdtr9bifsPPdeL9iuEwQXXqmyCsIPl2htLO2VE6kfXcLQ_Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDI54SBMXxFM8BuTAkWgrSZOVC-I18ZwQYtJuVdO6DMS6sY0Tfx47TUG7IKHemqSHz64_O3Fsxg5tkIdK2UhQ7TOBDKVEIk0gcpNFxxaaGBG4bIuOvu6q217Y8_lPE59WWdlEZ6izYUp75A0kLjqDQkJs5D4t4vGyfTr6ENRBik5afTuNebZolA5RwxfPrzqPT7-3JCPX9zFAhhW6KU2V1yN1g5pHT9-Kd9SZgLbtkNU12hAiHDt4m6WsWYvtaKi9wpa9_8jPSoGvsjko1ljtwZ-Qr7MvtEm8PQbgOaBfzfsJDIZU9eO14OWNyAmNDF0uFt2E5FUuKi9LyX6OgSdFxonwSGgntOxnZ4-jj-u__IIB_LTPqbfH-NVN3WDd9tXzxbXwDRaEDUwQCpmFSWSboJSUOTo2VA2wmegoNRg4pSbTgQUw-ELbLFLSIvypxCc9VrmE1MhNtlAMC9hiPEHI0JXLdZKEylpoyRZkkCuwoSVxbLMjRDIelSU0Yhd6SB1XwMcEfFwCj9EITg8qyP-xpl7JJvY_4iT-VZudv4cPWA31Kb6_6dztsiWnB26vpc4WEH3YQ9djave9Tn0DyDXWoA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=146+Free+fetal+haemoglobin+impacts+fetoplacental+vascular+structure+and+function%3A+implications+for+fetal+growth+restriction&rft.jtitle=Heart+%28British+Cardiac+Society%29&rft.au=Brook%2C+Adam&rft.au=Sneyd%2C+Rosie&rft.au=Gurung%2C+Rekha&rft.au=Hansson%2C+Stefan&rft.date=2017-06-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=1355-6037&rft.eissn=1468-201X&rft.volume=103&rft.spage=A108&rft_id=info:doi/10.1136%2Fheartjnl-2017-311726.145&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4322731687 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-6037&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-6037&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-6037&client=summon |